Literature DB >> 23328387

Domperidone and sudden cardiac death: How much longer should we wait?

Veronique Michaud, Jacques Turgeon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23328387     DOI： 10.1097/FJC.0b013e31827e2573

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN： 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  11 in total

1.  Should Domperidone be Used as a Galactagogue? Possible Safety Implications for Mother and Child.

Authors:  Luc M Hondeghem; Noël H Logghe
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

2.  Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada.

Authors:  Carlos Rojas-Fernandez; Anne L Stephenson; Hadas D Fischer; Xuesong Wang; Tiago Mestre; Janine R Hutson; Margarita Pondal; Douglas S Lee; Paula A Rochon; Connie Marras
Journal:  Drugs Aging       Date:  2014-11       Impact factor: 3.923

3.  A meta-analysis on the cardiac safety profile of domperidone compared to metoclopramide.

Authors:  Serhat Bor; Mesut Demir; Oktay Ozdemir; Kivanc Yuksel
Journal:  United European Gastroenterol J       Date:  2018-09-10       Impact factor: 4.623

4.  Interaction Between Domperidone and Ketoconazole: Toward Prediction of Consequent QTc Prolongation Using Purely In Vitro Information.

Authors:  H Mishra; S Polak; M Jamei; A Rostami-Hodjegan
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-08-13

5.  Domperidone, Parkinson disease and sudden cardiac death: Mice and men show the way.

Authors:  Fulvio A Scorza; Carla A Scorza; Henrique B Ferraz
Journal:  Clinics (Sao Paulo)       Date:  2016-02       Impact factor: 2.365

6.  Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis.

Authors:  Laura Kreckler; Mark Osinski; Scott Williams; Roger Whiting
Journal:  J Exp Pharmacol       Date:  2022-02-09

7.  The Effect of Ginger (Zingiber officinalis) and Artichoke (Cynara cardunculus) Extract Supplementation on Functional Dyspepsia: A Randomised, Double-Blind, and Placebo-Controlled Clinical Trial.

Authors:  Attilio Giacosa; Davide Guido; Mario Grassi; Antonella Riva; Paolo Morazzoni; Ezio Bombardelli; Simone Perna; Milena A Faliva; Mariangela Rondanelli
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-14       Impact factor: 2.629

8.  Safety, Pharmacokinetics, and Pharmacodynamics of Trazpiroben (TAK-906), a Novel Selective D2 /D3 Receptor Antagonist: A Phase 1 Randomized, Placebo-Controlled Single- and Multiple-Dose Escalation Study in Healthy Participants.

Authors:  Roger L Whiting; Borje Darpo; Chunlin Chen; Margaret Fletcher; Dan Combs; Hongqi Xue; Randall R Stoltz
Journal:  Clin Pharmacol Drug Dev       Date:  2021-01-18

9.  Mitigating Benzodiazepine Dependence and the Risk of Drug-Induced QTc Prolongation in the Treatment of Gastroparesis: A Case Report.

Authors:  Karley Tranchina; Derek Matlock; Carlos Hernandez; Jacques Turgeon; Jennifer M Bingham
Journal:  Medicina (Kaunas)       Date:  2022-03-10       Impact factor: 2.430

10.  Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906), a Peripherally Selective D2/D3 Dopamine Receptor Antagonist, in the Presence and Absence of Itraconazole, a Potent CYP 3A4 Inhibitor.

Authors:  Chunlin Chen; Wenwen Zhang; Muhammad Bari; Cristina Almansa; Mike Baratta; Maria Rosario
Journal:  Clin Pharmacol       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.